BeStock  
Markets › Compare › SUPN vs LNTH

SUPN vs LNTH

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SUPN · Supernus Pharmaceuticals$28.61 ▲ 0.92%
LNTH · Lantheus$102.10 ▲ 0.00%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5088127166205Nov 24, '25May 26, '26Nov 20, '26
  • SUPN -36.6%
  • LNTH +80.7%

Head to head

MetricSUPNLNTH
Price$28.61$102.10
Change today▲ 0.92%▲ 0.00%
Market cap$5.94B$6.68B
Return, 3 months-36.6%+1.3%
Return, year to date-42.4%+53.4%
Return, 1 year-36.9%+82.9%
P/E (TTM)–25.4
P/B5.64.9
P/E percentile vs own 5y20th68th
Dividend yield––
Revenue growth (YoY, latest qtr)+18.0%+1.5%
Net profit growth (YoY)+146.4%-19.4%
Gross margin87.6%61.3%
Operating margin3.2%18.6%
Net margin-5.1%17.3%
Return on equity-4.2%21.8%
Analyst target vs. price+83.9%+5.0%
Analyst buy share83%0%
RSI (14)3669
30-day volatility127.6%4.1%
Max drawdown, 1 year-53.6%-12.2%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LNTH is the largest of the group by market value.
  • LNTH has returned the most over the past year.
  • SUPN is growing revenue fastest.
  • LNTH keeps the most profit per dollar of sales.
  • LNTH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top